http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113861064-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0729b244445c470818ee3f4d96f79b1b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-42
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-42
filingDate 2021-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9f96c6725acc6ee27de3fffc111fb00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af7eeed4e183aef91e388ef70db68a99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d47316569fbbbc60a5e0207701309316
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b4120425f59313438f5a71e8d1b5fbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e8e7416f68744c97304b1e96edcd9bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_081ece3cc0fc4ef2283037ab686a3cfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bb3ae2fb0e70095cd92f1f1ac43fce8
publicationDate 2021-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113861064-A
titleOfInvention Neuroprotective agent and pharmaceutical use thereof
abstract A nerve protective agent and its pharmaceutical use, the structure conforms to the general formula (I), wherein: r 1 Or with R 2 Are linked to form a cyclic structure, R 2 =‑H、‑CH 3 Or with R 1 Are linked to form a cyclic structure, R 3 =‑OH、‑NH 2 、‑NHCH 3 、‑CH 2 NH 2 、‑CH 2 NHCH 3 or-COR 4 ,R 4 =‑OH、‑NH 2 、‑NHCH 3 Or alkoxy of 1 to 3 carbon atoms. The medicine has good effect in animal models such as cerebral apoplexy, and can be used for preparing medicine for treating cerebral apoplexy.
priorityDate 2021-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16051978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410443932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID256687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187201
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76507
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415760017
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2707
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10929
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414545698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535335
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447756586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421317016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410439549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424346164
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9086
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415907626
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8563
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450254702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8449
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559256

Total number of triples: 52.